• Users Online: 1705
  • Home
  • Print this page
  • Email this page
Year : 2013  |  Volume : 61  |  Issue : 9  |  Page : 523-525

Growth of Scytalidium sp. in a counterfeit bevacizumab bottle

1 Department of Retina, Asociacion para Evitar la Ceguera en Mexico, Mexico
2 Department of Microbiology Laboratory, Asociacion para Evitar la Ceguera en Mexico, Mexico
3 Department of Ophthalmology, Denver Health Medical Center, Denver, Colorado, USA

Correspondence Address:
Gerardo Garcia-Aguirre
Department of Retina, Asociacion Para Evitar la Ceguera en Mexico. Vicente Garcia Torres 46, San Lucas Coyoacan Mexico City, 04030
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0301-4738.119455

Rights and Permissions

After drawing a dose from an closed bevacizumab (Avastin) bottle, a fungus-like foreign body was observed inside. Samples from the vial were cultured in Sabouraud Emmons media. Growth of multiple light brown colonies with dark pigment was observed after 10 days. The species was identified as Scytalidium sp.Vial, analysis reported that the seal was lacking proper identification measures and that the label, batch number and expiry date did not correspond to a genuine product. Chemical analysis showed no protein, but 3% of polyethylene glycol, citrate and ethanol. Counterfeit bevacizumab is a real situation that poses a significant risk for ophthalmology and oncology patients. The medical community should be aware of this situation in order to enforce adequate preventive measures.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded160    
    Comments [Add]    
    Cited by others 5    

Recommend this journal